Dual bronchodilation vs triple therapy in the “real-life” COPD DACCORD study
Roland Buhl,1 Carl-Peter Criée,2 Peter Kardos,3 Claus F Vogelmeier,4 Konstantinos Kostikas,5 Nadine S Lossi,6 Heinrich Worth7 1Pulmonary Department, Mainz University Hospital, Mainz, 2Department of Sleep and Respiratory Medicine, Evangelical Hospital Goettingen-Weende, Bovenden, 3Group P...
Main Authors: | Buhl R, Criée C, Kardos P, Vogelmeier CF, Kostikas K, Lossi NS, Worth H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-08-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/dual-bronchodilation-vs-triple-therapy-in-the-real-life-copd-daccord-s-peer-reviewed-article-COPD |
Similar Items
-
“Real-life” inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD
by: Vogelmeier C, et al.
Published: (2017-02-01) -
A year in the life of German patients with COPD: the DACCORD observational study
by: Buhl R, et al.
Published: (2016-07-01) -
Prevention of copd exacerbations. Focus on dual bronchodilators
by: V. V. Arkhipov
Published: (2018-10-01) -
[Acute exacerbations in Chronic Obstructive Pulmonary Disease (COPD)]
by: Domenico Lorenzo Urso
Published: (2017-07-01) -
Exacerbations of COPD
by: Pavord ID, et al.
Published: (2016-02-01)